skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 25  for All Library Resources

Results 1 2 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Material Type:
Article
Add to My Research

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Nature communications, 2023-02, Vol.14 (1), p.824-824, Article 824 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-36561-6 ;PMID: 36788246

Full text available

2
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Material Type:
Article
Add to My Research

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

EBioMedicine, 2021-09, Vol.71, p.103561-103561, Article 103561 [Peer Reviewed Journal]

2021 The Author(s) ;Attribution - NonCommercial - NoDerivatives ;2021 The Author(s) 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103561 ;PMID: 34455390

Full text available

3
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
Material Type:
Article
Add to My Research

Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2

PLoS computational biology, 2023-08, Vol.19 (8), p.e1011282-e1011282 [Peer Reviewed Journal]

Copyright: © 2023 Clairon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Clairon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2023 Clairon et al 2023 Clairon et al ;ISSN: 1553-7358 ;ISSN: 1553-734X ;EISSN: 1553-7358 ;DOI: 10.1371/journal.pcbi.1011282 ;PMID: 37549192

Full text available

4
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Material Type:
Article
Add to My Research

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion

Nature communications, 2024-03, Vol.15 (1), p.2254-2254 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2024 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-46490-7 ;PMID: 38480689

Full text available

5
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
Material Type:
Article
Add to My Research

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine

Frontiers in immunology, 2022-02, Vol.13, p.790212 [Peer Reviewed Journal]

Copyright © 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer. ;Attribution ;Copyright © 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.790212 ;PMID: 35281046

Full text available

6
Divergent adaptive immune responses define two types of long COVID
Material Type:
Article
Add to My Research

Divergent adaptive immune responses define two types of long COVID

Frontiers in immunology, 2023-07, Vol.14, p.1221961-1221961 [Peer Reviewed Journal]

Copyright © 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti. ;Attribution ;Copyright © 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2023.1221961 ;PMID: 37559726

Full text available

7
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
Material Type:
Article
Add to My Research

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination

Viruses, 2022-07, Vol.14 (7), p.1491 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2022 by the authors. 2022 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v14071491 ;PMID: 35891471

Full text available

8
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study
Material Type:
Article
Add to My Research

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

EBioMedicine, 2021-11, Vol.73, p.103637-103637, Article 103637 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2021 The Authors 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103637 ;PMID: 34678613

Full text available

9
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
Material Type:
Article
Add to My Research

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study

EClinicalMedicine, 2022-09, Vol.51, p.101576-101576, Article 101576 [Peer Reviewed Journal]

2022 The Authors ;Attribution - NonCommercial - NoDerivatives ;2022 The Authors 2022 ;ISSN: 2589-5370 ;EISSN: 2589-5370 ;DOI: 10.1016/j.eclinm.2022.101576 ;PMID: 35891947

Full text available

10
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Material Type:
Article
Add to My Research

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

EBioMedicine, 2022-03, Vol.77, p.103934-103934, Article 103934 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2022.103934 ;PMID: 35290827

Full text available

11
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Material Type:
Article
Add to My Research

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Science Translational Medicine, 2020-09, Vol.12 (559) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1946-6234 ;EISSN: 1946-6242 ;DOI: 10.1126/scitranslmed.abc3103 ;PMID: 32817357

Digital Resources/Online E-Resources

12
Modeling the evolution of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
Material Type:
Article
Add to My Research

Modeling the evolution of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2

PLoS computational biology, 2023-07 [Peer Reviewed Journal]

Attribution ;ISSN: 1553-734X ;EISSN: 1553-7358

Full text available

13
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
Material Type:
Article
Add to My Research

Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells

Journal of virology, 2022-07, Vol.96 (14), p.e0060822-e0060822 [Peer Reviewed Journal]

Copyright © 2022 American Society for Microbiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.00608-22 ;PMID: 35862713

Full text available

14
Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab
Material Type:
Article
Add to My Research

Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab

American journal of transplantation, 2022-08, Vol.22 (8), p.2099-2103 [Peer Reviewed Journal]

2022 The American Society of Transplantation and the American Society of Transplant Surgeons. ;2022 The American Society of Transplantation and the American Society of Transplant Surgeons ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.17000 ;PMID: 35150193

Full text available

15
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Material Type:
Article
Add to My Research

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Proceedings of the National Academy of Sciences - PNAS, 2022-05, Vol.119 (20), p.e2120976119-e2120976119 [Peer Reviewed Journal]

Copyright National Academy of Sciences May 17, 2022 ;Attribution ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120976119 ;PMID: 35549549

Full text available

16
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
Material Type:
Article
Add to My Research

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Blood, 2022-02, Vol.139 (6), p.942-946 [Peer Reviewed Journal]

2022 American Society of Hematology ;Copyright ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013714 ;PMID: 34905598

Full text available

17
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Material Type:
Article
Add to My Research

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

Journal of virology, 2024-01 [Peer Reviewed Journal]

Copyright ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.01351-23 ;PMID: 38088562

Digital Resources/Online E-Resources

18
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
Material Type:
Article
Add to My Research

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection

The Journal of infectious diseases, 2021-11, Vol.224 (9), p.1489-1499 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab375 ;PMID: 34282461

Full text available

19
Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysis
Material Type:
Article
Add to My Research

Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysis

Clinical pharmacology and therapeutics, 2024-01 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.3069 ;PMID: 37795693

Digital Resources/Online E-Resources

20
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
Material Type:
Article
Add to My Research

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

Cell reports. Medicine, 2022-12, Vol.3 (12), p.100850-100850, Article 100850 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100850 ;PMID: 36450283

Full text available

Results 1 - 20 of 25  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (24)

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (1)
  3. 2021 To 2021  (7)
  4. 2022 To 2023  (14)
  5. After 2023  (3)
  6. More options open sub menu

Searching Remote Databases, Please Wait